Doctor profile · Federal record

Dr. Saritha Thumma, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Spokane, WA

  • NPI 1952445223
  • Accepts Medicare
  • 28 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
601 S Sherman St
Spokane, WA 992021311
(509) 228-1000
fax (509) 252-9300
Mailing address
1204 N Vercler RD
Spokane Valley, WA 992161020

Credentials & registration

NPPES · NUCC
NPI registered
February 2007 — 19 yrs on file
Profile last updated
January 8, 2025
Year of graduation
1998 — 28 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State licenses (2)
Washington #MD60012887 · Wisconsin #46748-020
Medicaid
WA #8513327

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1952445223. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
150,734
Distinct HCPCS
10
Medicare allowed
$2,339,543
HCPCS Description Services Patients Avg allowed
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram 35,940 20 $0
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram 23,880 14 $1
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 16,021 27 $46
J9271 Injection, pembrolizumab, 1 mg 14,004 21 $54
J0897 Injection, denosumab, 1 mg 13,740 69 $23
J0185 Injection, aprepitant, 1 mg 13,260 23 $2
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 9,135 62 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,884 82 $0
J9395 Injection, fulvestrant, 25 mg 2,860 19 $11
J0461 Injection, atropine sulfate, 0.01 mg 2,120 13 $0

In context: peer comparison

Among 11 peers in Spokane Hematology & Oncology Physician, average services per provider: 1,717. This provider delivers 88× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,501
Transactions
45
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 8 $334.45
Tempus Ai, INC 3 $221.76
AstraZeneca Pharmaceuticals Lp 8 $196.79
E.R. Squibb & Sons, L.L.C. 3 $60.26
Daiichi Sankyo INC. 3 $59.02
Blueprint Medicines Corporation 3 $55.15
Mirati Therapeutics, INC. 2 $52.76
Lilly USA, LLC 2 $49.00
Incyte Corporation 2 $47.48
Merck Sharp & Dohme LLC 2 $45.62
Janssen Biotech, INC. 2 $44.10
Celgene Corporation 2 $36.67
Gilead Sciences, INC. 2 $36.13
Puma Biotechnology, INC. 2 $33.98
Abbvie INC. 1 $33.08

By nature of payment

Food and Beverage
$1,249
Long Term Medical Supply or Device Loan
$199
Education
$52

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,056
Patients
605
Total drug cost
$1,000,384
Drug Type Claims Patients Total cost
Letrozole Generic 664 190 $19,539
Anastrozole Generic 487 136 $14,244
Alendronate Sodium Generic 202 62 $2,396
Gabapentin Generic 137 33 $3,169
Exemestane Generic 135 32 $28,084
Omeprazole Generic 62 19 $779
Potassium Chloride Generic 59 18 $2,226
Ibrance (Palbociclib) Brand 55 0 $893,909
Tamoxifen Citrate Generic 55 20 $2,654
Venlafaxine Hcl ER (Venlafaxine Hcl) Brand 45 15 $1,161

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Saritha Thumma's medical specialty?
Dr. Saritha Thumma practices Hematology & Oncology Physician in Spokane, WA.
Where does Dr. Saritha Thumma practice?
Dr. Saritha Thumma practices at 601 S Sherman St, Spokane, WA 992021311. Office phone: 5092281000.
What is Dr. Saritha Thumma's NPI?
Dr. Saritha Thumma's National Provider Identifier (NPI) is 1952445223, issued by NPPES.
Does Dr. Saritha Thumma accept Medicare assignment?
Yes. Dr. Saritha Thumma accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Saritha Thumma commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram (HCPCS Q5125); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.